A recent analysis from the University of Pittsburgh Medical Center highlights that nearly half of patients prescribed multitarget stool DNA…
Browsing: Clinical Updates
Guardant Health has announced that its Guardant Reveal test, a blood-based assay for minimal residual disease (MRD) detection, is now…
Oshi Health has released its 2024 Impact Report, showcasing the transformative impact of its virtual, multidisciplinary GI care model on…
The rising cost of colonoscopies and restrictive U.S. insurance policies are deterring young adults from timely colorectal cancer (CRC) testing,…
The Lancet Diabetes & Endocrinology recently published a proposal by 58 global experts advocating for a significant overhaul of how…
A new study published in JAMA Network Open cautions that prioritizing blood-based colorectal cancer (CRC) screening tests over stool-based tests…
AGA’s latest clinical practice update outlines what to do with nonampullary duodenal lesions. These polyps are found in up to…
In 2024, major drug approvals in gastroenterology and hepatology included FDA and EMA authorizations of biosimilars to Stelara and Humira…
Eli Lilly’s Omvoh® (mirikizumab-mkrz) has received FDA approval for treating moderately to severely active Crohn’s disease in adults, marking its…
Fractyl Health announced promising early results from the REVEAL-1 cohort of the REMAIN-1 study, showing weight maintenance one month after…